Research News

  • UVM Advances Child Brain Development Research
    In 2021, University of Vermont neuroscientists received a $5.5 million National Institute of Health (NIH) grant to support the Phase II segment of the HEALthy Brain and Child Development (HBCD) Study. The HBCD Study, the largest long-term study of early brain and child development in the United States, aims to comprehensively collect data on brain development from birth through early childhood, shedding light on the factors that shape a young person's life trajectory.
  • Advancing RSV Prevention: Diehl's Innovative Breakthroughs Drive New Antibody Treatment
    Larner Researcher’s Collaborative Efforts Propel RSV Vaccine Development and Offer Hope for Infant Health.
  • An Explores the Challenges and Promise of Medical Digital Twins
    Today, in the era of AI, medical digital twins hold great promise for helping diagnose and treat the population in the future. UVM Professor Gary An, M.D., a surgeon and computational biology and mathematical modeling expert, has been working on developing and researching computational models for such diseases as sepsis and COVID-19 for over 20 years. His recent research has centered on developing digital twins of the human immune system.
  • New Drug Gives Quality-of-Life Boost to Cancer Patients with Deadly Blood Clots
    Thanks to positive results from a new clinical trial in which the UVM Cancer Center and Chris Holmes, M.D., Ph.D., professor of medicine, played a role, the five to 25 percent of cancer patients who develop venous thrombosis will no longer need to inject themselves with a blood thinner.
  • Kanayo Ikeh Named UVM Cancer Center Juckett Scholar
    This summer, 20 summer scholars were awarded $4,000 stipends to deepen their engagement, hone their skills, and drive towards new discoveries under the guidance of a UVM Cancer Center mentor. Among the group is Kanayo Ikeh, this year’s 2023 Juckett Summer Student Scholar.
  • Mental Health Care for Children Lagging After Firearm Injury, Study Finds
    A study by UVM researchers and colleagues finds mental health care lagging after firearm injury, which increases risk for serious mental health conditions.
  • Medical Students Present Public Health Projects at Community Celebration
    Class of 2026 Larner College of Medicine students researched Vermont’s most timely public health and social needs, revealing important findings that will help shape direction for social service agencies. The students shared their findings at community celebration in on May 31.
  • Botten & Celdara's NIH Grant to Help Develop Therapeutic Antibodies for Deadly Disease
    Celdara Medical and UVM Professor of Medicine Jason Botten, Ph.D., have received a Phase II Small Business Technology Transfer grant from the National Institute of Allergy and Infectious Diseases that will support the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome – a severe respiratory disease caused by rodent-borne hantaviruses.
  • Improving Diversity in Heart Disease Clinical Research: Study Examines Efficacy of Digital Tools
    A new study at the University of Vermont is exploring whether inviting Black people to help design digital recruitment approaches will better engage Black adults and increase participation in trials.
  • First-Ever Millennial Lung Health Study Launches in Vermont
    On May 17, 2023, the University of Vermont’s Vermont Lung Center and the American Lung Association announced Vermont’s participation as one of 35 sites across the country conducting a first-of-its-kind large-scale study of millennial lung health - the Lung Health Cohort Study.